Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Claudia Claus has a total of 193 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RhoB supports rubella infection and impairs endothelial barrier integrity through downstream ROCK signaling

    by Igor Kovacevic, Marie Müller, Leonie Mair, Vivien Henschke, Annkatrin Kowalski, Jes-Niels Boeckel, Karolin Kropf, Guido Posern, Uta Reibetanz, Claudia Claus

    Background: During infection, alterations of the endothelium’s barrier function are multifaceted and virus-specific. Rubella virus (RuV) infection during pregnancy damages the endothelium in the placental and fetal vasculature, thereby contributing to the development of congenital rubella syndrome. However, the extent and mechanisms behind RuV-induced endothelial barrier disruption have not been previously documented. Methods: To investigate if RuV directly impairs endothelial barrier integrity, we infected primary human umbilical vein endothelial cells and analyzed the barrier integrity using Electrical Cell-Substrate Impedance Sensing (ECIS). Furthermore, we applied fluorescence microscopy to analyze RuV-induced changes in cell morphology, the actin cytoskeleton, and cell–cell junctions. To dissect the molecular mechanisms behind the observed alterations induced by RuV infection in endothelial cells, we determined levels of RhoA and RhoB GTPases, followed by depletion of both proteins using siRNA transfection and application of pharmacological inhibitors of the Rho/ROCK signaling axis. Results: Rubella virus infection in endothelial cells induced a comparatively low level of cytopathogenicity, accompanied by an elongated morphology. Most notably, a reduction in endothelial barrier integrity occurred at later time points of infection, as measured by ECIS. While the overall expression levels of junctional proteins appeared unaffected, membrane localization of zonula occludens-1 (ZO-1) was significantly reduced. This was accompanied by a marked increase in actin stress fibers and enhanced RhoB GTPase levels. The siRNA-mediated downregulation combined with time-dependent inhibitor application confirmed a contributory role for RhoB to RuV infection at early post-entry steps. The elongated morphology of infected endothelial cells was associated with the chemokine CCL5. Notably, cell elongation induced by treatment with supernatant from infected cells was insufficient to impair the barrier integrity in the absence of productive RuV replication. In comparison, depletion of RhoB expression or ROCK inhibitor application revealed the involvement of the RhoB/ROCK signaling axis in the impairment of barrier integrity and induction of stress fibers by RuV infection. Additionally, altered localization of ZO-1 was restored after application of ROCK inhibitor Y-27632 to uninfected control levels. Conclusions: Collectively, our data highlight the involvement of Rho GTPase–ROCK signaling in alterations of endothelial cell actin dynamics and barrier integrity in rubella virus pathology.


  • Open Access

    A renewed perspective on TCA intermediate cis-aconitate: mechanisms and therapeutic options against influenza virus

    by Claudia Claus, Igor Kovacevic

    Effective therapeutic strategies for influenza, ranging from seasonal flu outbreaks to sporadic pandemics, should ideally combine antiviral efficacy to accelerate viral clearance with targeted immunomodulation to mitigate excessive inflammation. In this issue of EMBO Molecular Medicine, Cezard et al introduce the inhibitory potential of the tricarboxylic acid (TCA) cycle intermediate cis-aconitate against influenza virus. Cis-aconitate is promising for further translational evaluation, as it meets the dual targeting criteria of antiviral and anti-inflammatory activity at both early as well as late stages of infection. Remarkably, these effects occur independently of its conversion into itaconate, a well-characterized immunomodulatory TCA derivative. This novel aspect of cis-aconitate further supports continued consideration of TCA cycle intermediates beyond their canonical metabolic roles. C. Claus and I. Kovacevic discuss the identification of cis-aconitate, a mitochondria-derived metabolite, with dual antiviral and anti-inflammatory activity against influenza, as reported by M. Si-Tahar and colleagues, in this issue of EMBO Mol Med.

  • Open Access

    Tailoring PEGDA/gelatin hydrogels with silver nanoparticles: Mechanical characterization and bacterial inhibition studies

    by Tuğçe Şener Raman, Claudia Claus, Olesya Daikos, Tom Scherzer, Andrea Prager, Andriy Lotnyk, Lena Stieler, Robert Konieczny, Norman Lippmann, Anette Kaiser, et al.


  • Open Access

    Study of the Influence of Structure-Chemical Properties of Electron Beam-Polymerized PEGDA/Gelatin Hybrid Hydrogels on the Uptake and Release Dynamics of Different Photosensitizer Molecules

    by Tuğçe Şener Raman, Claudia Claus, Bernd Abel, Agnes Schulze

    Hybrid hydrogels are promising for wound dressing, tissue engineering, and drug delivery due to their exceptional biocompatibility and mechanical stability. This study synthesized hybrid hydrogels for photodynamic therapy using electron beam-initiated polymerization with varying PEGDA/gelatin ratios and irradiation doses to evaluate their effectiveness as uptake and release systems for five photosensitizers. Toluidine blue, O (TBO); methylene blue (MB); eosin, Y; indocyanine, green; and sodium meso-tetraphenylporphine-4,4',4″,4‴-tetrasulfonate were studied for their uptake and release dynamics in relation to their structural properties and the hydrogels' composition. Uptake was influenced by the gelatin ratio and ionic properties, with anionic photosensitizers achieving over 80% uptake while cationic ones remained below 45%. Increased irradiation doses highlighted the roles of ionic interactions, hydrophilicity, and surface polarity. Cationic photosensitizers produced singlet oxygen 9-10 times more efficiently. Nontoxic PEGDA/gelatin hydrogels demonstrated photosensitizer-dependent cytotoxicity, with TBO and MB consistent with previous findings. These results confirm their potential in photodynamic therapy.


  • Open Access

    Rubella virus-associated uveitis at a tertiary care hospital in Germany between 2013 and 2019

    by Mario Hönemann, Elizabeth Scharfenberg, Nadine Dietze, Claudia Claus, Claudia Jochmann, Uwe Gerd Liebert

    Uveitis is a process of intraocular inflammation that may involve different sections of the uveal tract. Apart from systemic or localized immune-mediated diseases, infections are key players in the etiology of uveitis and entail different treatment strategies. Rubella virus (RuV) is a recognized causative agent for the development of Fuchs uveitis, representing a major cause of virus-associated intraocular inflammation. A cohort of 159 patients diagnosed with different forms of uveitis between 2013 and 2019 was subjected to diagnostic antibody testing of the aqueous or vitreous humor. The diagnostic panel included RuV, cytomegalovirus, herpes simplex virus, varicella-zoster virus, and toxoplasmosis. Within this cohort, 38 RuV-associated uveitis (RAU) patients were identified based on a pathologic Goldman-Witmer coefficient indicative of an underlying RuV infection. With a mean age of 45.9 years, the RAU patients were younger than the non-RAU patients (56.3, p < 0.001). The evaluation of clinical parameters revealed a predominance of anterior uveitis and late sequalae such as cataract and glaucoma among the RAU patients. In 15 of the patients a history of prior RuV infections could be confirmed. The study underlines the importance of long-term surveillance of RuV associated diseases that originate from infections before the introduction of RuV vaccination programs.

  • Open Access

    Dissecting Rubella Placental Infection in an In Vitro Trophoblast Model

    by Juliane Schulz, Erik Schilling, Claire Fabian, Ana Claudia Zenclussen, Violeta Stojanovska, Claudia Claus

    Vertical transmission of rubella virus (RuV) occurs at a high rate during the first trimester of pregnancy. The modes of vertical transmission including the response of trophoblasts to RuV are not well understood. Here, RuV-trophoblast interaction was studied in the BeWo trophoblast cell line. Analysis included early and late time-point kinetics of virus infection rate and the antiviral innate immune response at mRNA and protein level. BeWo characteristics were addressed through metabolic activity by extracellular flux analysis and syncytiotrophoblast formation through incubation with forskolin. We found that RuV infection of BeWo led to profuse type III interferon (IFN) production. Transfecting trophoblast cells with dsRNA analog induced an increase in the production of type I IFN-β and type III IFNs; however, this did not occur in RuV-infected BeWo trophoblasts. IFN-β and to a lesser extent type III IFN-λ1 were inhibitory to RuV. While no significant metabolic alteration was detected, RuV infection reduced the cell number in the monolayer culture in comparison to the mock control and resulted in detached and floating cells. Syncytia formation restricted RuV infection. The use of BeWo as a relevant cell culture model for infection of trophoblasts highlights cytopathogenicity in the absence of a type I IFN response as a pathogenic alteration by RuV.


  • Open Access

    Generation of a set of induced pluripotent stem cell lines from two Alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 (MLUi009-A; MLUi010-B) to study APOE in aging and disease

    by Matthias Jung, Carla Hartmann, Toni Ehrhardt, Lisa-Maria Peter, Chaudhry Luqman Abid, Bernadette Harwardt, Jana Hirschfeld, Claudia Claus, Undine Haferkamp, Ole Pless, et al.


  • Open Access

    Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10

    by Vivien Henschke, Konstanze Hild, Erik Schilling, Jan Haas, Vanina Filipova, Stephan Erbe, Roman König, Judith M. Hübschen, Ulrich Laufs, Claudia Claus, et al.


  • Open Access

    Ivermectin Inhibits the Replication of Usutu Virus In Vitro

    by Maria Elisabeth Wald, Claudia Claus, Andrea Konrath, Hermann Nieper, Aemero Muluneh, Volker Schmidt, Thomas Wilhelm Vahlenkamp, Michael Sieg

    Usutu virus (USUV) is an emerging mosquito-borne arbovirus within the genus Flavivirus, family Flaviviridae. Similar to the closely related West Nile virus (WNV), USUV infections are capable of causing mass mortality in wild and captive birds, especially blackbirds. In the last few years, a massive spread of USUV was present in the avian population of Germany and other European countries. To date, no specific antiviral therapies are available. Nine different approved drugs were tested for their antiviral effects on the replication of USUV in vitro in a screening assay. Ivermectin was identified as a potent inhibitor of USUV replication in three cell types from different species, such as simian Vero CCL-81, human A549 and avian TME R. A 2- to 7-log10 reduction of the viral titer in the supernatant was detected at a non-cytotoxic concentration of 5 µM ivermectin dependent on the applied cell line. IC50 values of ivermectin against USUV lineage Africa 3 was found to be 0.55 µM in Vero CCL-81, 1.94 µM in A549 and 1.38 µM in TME-R cells. The antiviral efficacy was comparable between the USUV lineages Africa 2, Africa 3 and Europe 3. These findings show that ivermectin may be a candidate for further experimental and clinical studies addressing the treatment of USUV disease, especially in captive birds.


  • Open Access

    Women in the European Virus Bioinformatics Center

    by Franziska Hufsky, Ana Abecasis, Patricia Agudelo-Romero, Magda Bletsa, Katherine Brown, Claudia Claus, Stefanie Deinhardt-Emmer, Li Deng, Caroline C. Friedel, María Inés Gismondi, et al.

    Viruses are the cause of a considerable burden to human, animal and plant health, while on the other hand playing an important role in regulating entire ecosystems. The power of new sequencing technologies combined with new tools for processing “Big Data” offers unprecedented opportunities to answer fundamental questions in virology. Virologists have an urgent need for virus-specific bioinformatics tools. These developments have led to the formation of the European Virus Bioinformatics Center, a network of experts in virology and bioinformatics who are joining forces to enable extensive exchange and collaboration between these research areas. The EVBC strives to provide talented researchers with a supportive environment free of gender bias, but the gender gap in science, especially in math-intensive fields such as computer science, persists. To bring more talented women into research and keep them there, we need to highlight role models to spark their interest, and we need to ensure that female scientists are not kept at lower levels but are given the opportunity to lead the field. Here we showcase the work of the EVBC and highlight the achievements of some outstanding women experts in virology and viral bioinformatics.